Suppression of oxidative stress via knockdown of NOX2 and NOX4 is reported to attenuate cardiac remodeling and dysfunction [3], supporting the potential utility of antioxidative therapy as a novel strategy for MI. The gene discussed is NOX4; the disease is myocardial infarction.